HIGH

Zydus Chlorpromazine Hydrochloride 200 mg Recall Expands Nationwide Over CGMP Deviations

The FDA confirms a nationwide recall of Zydus Lifesciences Chlorpromazine Hydrochloride tablets 200 mg (NDC 70710-1133-1) distributed by Zydus Pharmaceuticals USA. The recall cites CGMP deviations and the presence of N-Nitroso Desmethyl Chlorpromazine above acceptable intake. Consumers and healthcare providers should stop using the product immediately and contact the distributor for guidance.

Quick Facts at a Glance

Recall Date
September 3, 2025
Hazard Level
HIGH
Brands
Chlorpromazine Hydrochloride, Zydus Pharmaceuticals, Zydus Lifesciences
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, ELDERLY

Hazard Information

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Zydus Pharmaceuticals (USA) Inc or your healthcare provider for guidance. Notification method: N/A

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Chlorpromazine hydrochloride is an antipsychotic medication used to treat manic depression and schizophrenia symptoms.

Why This Is Dangerous

The impurity N-Nitroso Desmethyl Chlorpromazine above acceptable intake could pose health risks; CGMP deviations indicate manufacturing quality concerns.

Industry Context

This recall is not part of a broader pattern in the industry.

Real-World Impact

No injuries reported yet. The recall focuses on product safety and potential long-term health risks.

Practical Guidance

How to identify if yours is affected

  1. Verify NDC 70710-1133-1 on the bottle
  2. Check lot numbers if provided
  3. Confirm packaging shows Zydus Lifesciences or Zydus Pharmaceuticals logos

Where to find product info

FDA recall page and manufacturer contact; packaging details on label

What timeline to expect

No timeline provided; monitor FDA updates

If the manufacturer is unresponsive

  • Document all contact attempts
  • File a consumer complaint with FDA MedWatch if supplier unresponsive
  • Consult healthcare provider for alternatives

How to prevent similar issues

  • Verify NDC before dispensing to patients
  • Follow CGMP compliance updates for suppliers
  • Ask for documentation of manufacturing standards when sourcing drugs

Documentation advice

Keep bottle, packaging, recall notice, and correspondence with supplier

Product Details

Brand: Chlorpromazine Hydrochloride. Manufacturer: Zydus Lifesciences Ltd., Baddi, India. Distributor: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1133-1. Quantity and packaging: 100-count bottle. Sold nationwide in the USA. Recall date: 2025-09-03. Status: Active.

Reported Incidents

No specific consumer injuries or incidents are reported in the notice.

Key Facts

  • NDC 70710-1133-1
  • Manufactured by Zydus Lifesciences Ltd. (Baddi, India)
  • Distributed by Zydus Pharmaceuticals (USA) Inc. (Pennington, NJ)
  • Class II recall
  • Recall date 2025-09-03
  • Active status

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTELDERLYPREGNANT
Injury Types
POISONINGOTHER

Product Details

Model Numbers
Z305083
Z305084
Z305468
Z305469
Z305470
+7 more
UPC Codes
70710-1129
70710-1130
70710-1131
+12 more
Affected States
ALL
Report Date
September 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more